{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-017164","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.970928+00:00","generated_at":"2026-06-16T02:22:49.653725+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Achieve Life Sciences updates principal executive offices to two locations effective April 28, 2023","bullets":["Effective April 28, 2023, Achieve Life Sciences established principal executive offices at 1040 West Georgia, Suite 1030, Vancouver, BC, Canada V6E 4H1.","Also effective April 28, 2023, the Company's principal executive offices include 22722 29th Drive SE, Suite 100, Bothell, WA 98021.","The address change was disclosed under Item 7.01 Regulation FD Disclosure in an 8-K filed May 3, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-017164","json":"https://secwatch.observer/filing/0000950170-23-017164.json","markdown":"https://secwatch.observer/filing/0000950170-23-017164.md","text":"https://secwatch.observer/filing/0000950170-23-017164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000095017023017164/0000950170-23-017164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000095017023017164/achv-20230428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T02:22:49.653725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}